CARING FOR THE CRITICALLY ILL PATIENT Dexmedetomidine vs Midazolam or Propofol for SedationDuringProlongedMechanicalVentilation Two Randomized Controlled Trials

Content Provider	Semantic Scholar
Author	Jakob, Stephan M. Ruokonen, Esko Grounds, Robert Michael Sarapohja, Toni Garratt, Chris Pocock, Stuart J. Bratty, J. Raymond Takala, Jukka
Copyright Year	2012
Abstract	SEDATION IN INTENSIVE CARE PAtients is assumed to reduce discomfort from care interventions, increase tolerance of mechanical ventilation, prevent accidental removal of instrumentation, and reduce metabolic demands during cardiovascular and respiratory instability. Long-term sedation may have serious adverse effects, such as prolonged mechanical ventilation, coma, delirium, delusional memories and posttraumatic stress disorder, impaired cognitive function, prolonged hospitalization, increased costs, and mortality. Daily sedation stops, sedation protocols, spontaneous breathing trials and early mobilization, or primary use of opiates without other sedation may help reduce these complications. Current sedatives are problematic in long-term sedation. Benzodiazepines and propofol accumulate unpredictably. High-dose or prolonged propofol use may cause potentially fatal propofol infusion syndrome. Dexmedetomidine, a sedative with high
File Format	PDF HTM / HTML
Alternate Webpage(s)	http://jama.jamanetwork.com/pdfaccess.ashx?url=/data/journals/jama/22494/jce20000_1151_1160.pdf
Alternate Webpage(s)	http://www.henryfordem.com/ground/ul/1416_20120414211548_ho.pdf
Alternate Webpage(s)	http://paccm.pitt.edu/MICU/PACCM_Fellows_Ed_2017/articlesPowerpoints/ICU%20sedation/dex%20vs%20midaz%20vs%20propofol%20JAMA.pdf
Language	English
Access Restriction	Open
Content Type	Text
Resource Type	Article